NGS Sample Preparation Market Size is Worth USD 10,342.23 Million by 2032

Emergen Research

The increased advancements in NGS platforms, a decrease in the price of sequencing, and improving the NGS-based diagnostic test reimbursement scenario are driving the demand for the Next Generation Sequencing (NGS) Sample Preparation market

Vancouver, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The global next generation sequencing (NGS) sample preparation Market is expected to reach USD 6,630.0 Million by 2032, according to a new report by Emergen Research. Numerous advantages of high-performance sequencing compared to technologies used in the field of genetics, including microarray and sanger-seq, are among the significant factors fueling the NGS sample preparation market growth. In addition, it is estimated that the availability of sampling techniques with low input DNA reduces overall costs is that, expanding the use of next-generation sequencing in various scientific and clinical applications.

New England Biolabs technology that uses magnetic beads to mount the prototype will greatly enhance the procedures for NGS sample preparation for the next generation. Recent advances in technology, for example, the LIMS, for automation of genome libraries, often allow for single day next-generation sequencing at an affordable cost. The progress is expected to increase the number of next-generation users in the forecast period.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @  https://www.emergenresearch.com/request-sample/77

This NGS technology has drawn the interest of many companies and investors in various fields, including fundamental research, discovery, and production of pharmaceutical drugs, reproductive, and consumer genomics. Moreover, the dropping costs and the added value of next-generation sequencing data relative to traditional data are anticipated to have a positive impact on this technology's diversification in other clinical areas and result in lucrative revenue growth.

Scope of Research

Report Details	Outcome
Market size value in 2019	USD 3,110.0 million
CAGR (2023–2032)	9.3%
Revenue forecast to 2032	USD 10,342.23 million
Base year for estimation	2019
Historical data	2019–2021
Forecast period	2023–2032
Quantitative units	Revenue in USD Billion and CAGR in % from 2023 to 2032
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Workflow, application, end-users, region
Regional scope	North America; Europe; Asia Pacific; Central & South America; MEA
Country scope	U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiled	include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd., Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among others, among others
Customization scope	10 hrs of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/77

MAJOR COMPANIES and Market Share Analysis

The leading players in the next generation sequencing (NGS) sample preparation market are equipped with enhanced production facilities and are involved in various R&D activities. A few leading players in the next generation sequencing (NGS) sample preparation market include:

• Agilent Technologies

• Bio-Rad Laboratories Inc.

• Biomatters Ltd.

• Congenica Ltd.

• Eurofins Scientific

• DNASTAR

• F. Hoffmann-La Roche Ltd.

• Genomatix GmbH

• Thermo Fisher Scientific

• Foundation Medicine

Strategic Development

In July 2019, next generation sequencing (NGS) assays for Non-small cell lung cancer (NSCLC) had been signed with Thermo Fisher Scientific by Biodesix, Inc. FDA-Premarket approval (PMA) classification is also being pursued by the client.

Key Highlights from The Report

• By workflow, clonal amplification is likely to grow at the fastest rate of 9.5% in the forecast period in next generation sequencing (NGS) sample preparation market. Library clonal amplification helps in the generation of numerous copies of target interest areas. Clonal amplification automation offers to allow for simultaneous preparation of multiple libraries sequencing templates, thereby decreasing the preparation time of the sample.

• By application, oncology, in terms of market size, dominated the next generation sequencing (NGS) sample preparation market in 2019. NGS, in comparison to traditional techniques, provides precision, rapidity, and sensitivity benefits with the potential to have a substantial impact on the oncology field, as NGS possess the ability to evaluate multiple genes in a single assay, thereby eradicating the necessity to order several tests for ascertaining the causative mutation.

• By end-users, academic research held the largest next generation sequencing (NGS) sample preparation market share of over 53.0% in the year 2019 because of the high penetration of research activities through seq-technology. This technology, on the other hand, is continuously growing in clinical and clinical research.

• The emergence of an integrated platform based in the USA has accounted for North America's highest revenue share. Asia-Pacific is projected to expand fastest as domestics in China are growing, along with molecular diagnostics. Asia-Pacific is anticipated to register a CAGR of 11.5% during the forecast period in next generation sequencing (NGS) sample preparation market.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/77

Emergen Research has segmented the global next generation sequencing (NGS) sample preparation market on the basis of workflow, application, end-users, and region:

• Workflow Outlook (Revenue, USD Billion; 2019-2032)

  • NGS Library Preparation Kit

  • Semi-Automated Library Preparation

  • Automated Library Preparation

  • Colonial Amplification

• Application Outlook (Revenue, USD Billion; 2019-2032)

  • Oncology

  • Clinical Investigation

  • Reproductive Health

  • HLA Typing/Immune System Monitoring

  • Metagenomics, Epidemiology, & Drug Development

  • Agrigenomics & Forensics

  • Consumer Genomics

• End-Users Outlook (Revenue, USD Billion; 2019-2032)

  • Academic Research

  • Clinical Research

  • Hospitals & Clinics

  • Pharma & Biotech  Entities

  • Others

• Regional Outlook (Revenue, USD Billion; 2019-2032)

  • North America

    1. U.S.

    2. Canada

  • Europe

    1. Germany

    2. UK

    3. France

    4. BENELUX

    5. Rest of Europe

  • Asia Pacific

    1. China

    2. Japan

    3. South Korea

    4. Rest of APAC

  • Latin America

    1. Brazil

    2. Rest of LATAM

  • MEA

    1. Saudi Arabia

    2. UAE

    3. Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics @  https://www.emergenresearch.com/industry-report/next-generation-sequencing-sample-preparation-market

Curated Reports You Shouldn't Miss: Dive In Now!

Alternative Proteins Market, By Source (Plant-based, Insect-based, Microbial-based) By Application (Meat Substitutes, Dairy Alternatives, Bakery, Nutrient Supplement), By Form (Dry Form, Wet Form), and By Region Forecast to 2030

Biologics Market, By Source (Microbial and Mammalian), By Product Type (Monoclonal Antibodies, Vaccines, Cellular-Based Biologics, and Gene-Based Biologics), By Application, and By Region Forecast to 2030

Blockchain in Healthcare Market By Type (Permissioned/Private Blockchain, Permissionless/Public Blockchain), By Application, By End-Users (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), Forecasts to 2027

Cancer Immunotherapy Market, By Technology (Monoclonal Antibodies, Vaccines, Immunomodulators), By Application (Lung Cancer, Breast Cancer, Ovarian Cancer, Blood Cancer, Others), By End-Use, and By Region Forecast to 2030

Clinical Decision Support System Market, By Type (Standalone CDSS, Integrated EHR with CDSS), By Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders), By Delivery Mode, and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Explore Japanese Version: Next Generation Sequencing (NGS) Sample Preparation Market

Read our Press Release @ https://www.emergenresearch.com/press-release/global-next-generation-sequencing-sample-preparation-market